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ABSTRACT
We propose a novel single-deoxynucleoside-based assay that is easy to perform 
and provides accurate values for the absolute length (in units of time) of each of the 
cell cycle stages (G1, S and G2/M).  This flow-cytometric assay takes advantage of the 
excellent stoichiometric properties of azide-fluorochrome detection of DNA substituted 
with 5-ethynyl-2′-deoxyuridine (EdU). We show that by pulsing cells with EdU for 
incremental periods of time maximal EdU-coupled fluorescence is reached when 
pulsing times match the length of S phase. These pulsing times, allowing labelling 
for a full S phase of a fraction of cells in asynchronous populations, provide accurate 
values for the absolute length of S phase. We characterized additional, lower intensity 
signals that allowed quantification of the absolute durations of G1 and G2 phases. 
Importantly, using this novel assay data on the lengths of G1, S and G2/M phases 
are obtained in parallel. Therefore, these parameters can be estimated within a time 
frame that is shorter than a full cell cycle. This method, which we designate as EdU-
Coupled Fluorescence Intensity (E-CFI) analysis, was successfully applied to cell types 
with distinctive cell cycle features and shows excellent agreement with established 
methodologies for analysis of cell cycle kinetics.
 INTRODUCTION 
The rate at which mammalian cells entry and progress 
through the different stages of their cell cycle is subject 
to strict regulatory mechanisms to avoid abnormal cell 
growth and division that may pose a threat to structure and 
function at the tissue level [1]. Intensive efforts have been 
done to accurately monitor cell cycle progression in order 
to better understand and predict tumor development [2]. 
By identifying changes in proliferation rates in response 
to treatment important contributes can be made to the 
development of anti-cancer therapeutic agents targeting 
specific steps of the cell cycle and the tailoring of treatment 
strategies for oncologic patients. In addition, determining 
cell cycle kinetics for distinct cell cycle stages is an 
important step for characterization of cancer cell lines [3]. 
Kinetics of S phase, in particular, can provide 
important information on control mechanisms and shifts in 
DNA replication. For instance, during early embryogenesis 
changes in S phase duration are frequent and reflect a 
progressive slowing down of firing rates of replication 
origins [4], while neuronal progenitor cells seem to shorten 
their S phase as they switch transcription factors on the 
path to neuron differentiation [5].
Currently, various techniques are available to 
estimate the duration of specific cycle phases, each with 
particular advantages and short-comings. Possibly the 
quickest, easiest and most widely used approach is to stain 
cellular DNA with a fluorescent dye to measure the DNA 
content of a cell population using flow cytometry analysis. 
With the aid of statistical algorithms implemented within 
the analysis software this results in the distribution of 
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cells along the G1/G0 (2n), G2/M (4n) and S (2n to 4n) 
phases of the cycle [6, 7]. This method, however, only 
provides cell cycle distributions – i.e. relative lengths - at 
a fixed time point and suffers from variability associated 
with technical artifacts introduced by sample preparation, 
and density and condition of cells that can interfere with 
a uniform staining of cellular DNA [8]. Furthermore, 
the use of different statistical algorithms potentially 
introduces additional variability in the interpretation of 
DNA measurements between laboratories [9, 10]. 
Higher sensitivity strategies providing data on 
absolute durations of each stage of the cell cycle usually 
involve incorporation of detectable nucleoside analogues, 
the most widely used being the thymidine analogue BrdU 
(5-bromo-2′-deoxyuridine). BrdU is incorporated into 
cellular DNA during replication to tag cells in S phase, 
allowing their identification by immunofluorescence 
microscopy or flow cytometry [11]. BrdU has become 
standard use in proliferation studies for the past two 
decades as it significantly reduced the cost and time 
associated with previously used radioactive analogues (e.g. 
tritium-labelled thymidine). A drawback, however, is that 
antibody-based detection of BrdU has poor stoichiometry 
and requires a DNA denaturation step. This step, essential 
to expose incorporated BrdU to antibodies, can induce 
degradation of DNA structure and cause variability in the 
detected fluorescent signals [12]. 
In one immunofluorescence microscopy-based 
approach cell populations are briefly pulsed with BrdU to 
mark cells traversing S phase, and subsequently checked 
in mitosis over incremental chasing periods. Parameters 
on cell cycle phases can then be estimated from the 
time required for BrdU-labelled cells to reach M phase, 
yielding absolute G2 duration, and from the time BrdU-
positive cells persist showing up in mitosis, corresponding 
to absolute S phase duration [13, 14]. This method boasts 
high resolution and reproducibility, although the technical 
steps involved in sample preparation and microscopic 
analysis can be very time consuming. Instead of screening 
for tagged mitotic fractions to identify cells that have left 
S phase other options involve pulsing replicating cells 
with two distinct nucleoside analogues at different times; 
or else, synchronizing the entire cell population to ensure 
an homogeneous entry in S phase and removal of the 
noise associated with double-pulsing methods [15]. Dual 
labelling requires the simultaneous use and detection of 
two antibodies specific for different analogues, hence 
special care needs to be taken to avoid cross hybridization 
signals [16]. Cell synchronization, on the other hand, 
carries the risk of disturbing normal cycle progression and 
inducing cell death, even when performed avoiding the 
use of drugs that target the cell cycle [17]. 
In recent years another thymidine analogue, EdU 
(5-ethynyl-2′-deoxyuridine), has become established 
as a viable alternative to BrdU for labeling replicating 
DNA. EdU harbours a terminal alkyne group that can 
be detected by its highly specific covalent reaction with 
a fluorochrome-conjugated azide. This property confers 
several advantages over BrdU, namely extremely high 
sensitivity and ease of use, along with the small size and 
high intracellular penetration capability of EdU reagents 
(1/500th the size of an antibody molecule). This eliminates 
the need for the harsh cell permeabilization and DNA 
denaturation steps typical of antibody-based detection 
techniques [12, 18]. The characteristics of the EdU-
azide reaction further suggest the potential for optimum 
stoichiometry detection of EdU incorporated into DNA by 
a quantitative methodology such as flow cytometry. 
We therefore reasoned that, instead of just scoring 
fractions of EdU-positive cells, it would be possible to 
extract accurate information on the kinetics of S phase by 
measuring the fluorescent intensities stemming from EdU-
substituted DNA (EdU-DNA). The basic assumption was 
that, by pulsing asynchronous cell populations with EdU 
for incremental periods of time, when pulsing times match 
the length of S phase at least a cohort of cells would be 
labelled for a full S phase. These cells should thus show 
maximum labelling intensity, and the corresponding 
pulsing time should equal the absolute length of S phase. 
Further increments in pulsing times should only increase 
the percentage of cells featuring such intensities. 
Herein, we provide compelling evidence that this 
principle can be applied to measure the length of S phase 
with high temporal resolution even under conditions where 
cell cycle progression is perturbed. Furthermore, analysis 
of the fluorescence intensity plots obtained by flow 
cytometry also yields additional useful information on the 
lengths of G1 and G2 phases of the cell cycle. This novel 
method, designated here as EdU-Coupled Fluorescence 
Intensity (E-CFI) analysis, can be used to characterize cell 
types featuring highly distinct cell cycle characteristics. 
RESULTS 
Effects of EdU on DNA damage response, 
genomic instability and cell cycle progression 
Replacement of natural thymidine by halogenated 
or alkylated analogues, including EdU, has been shown 
to introduce conformational changes in the DNA helix 
and nucleotide pool imbalance; also, alterations in DNA 
synthesis and cell cycle progression, DNA damage and 
genomic instability, and increased cell death [19]. We have, 
therefore, tested the potentially noxious effects of EdU on 
HCT-116 cells to establish temporal and dosage constraints 
to the use of EdU in estimating cell cycle parameters. 
To this end, HCT-116 cells were synchronized at the 
G1/S transition by a double thymidine block and exposed 
to a range of EdU concentrations (5, 10, 20 and 30 µM) 
for a full S phase (see materials and methods). Cells were 
then analyzed 5 days later for the presence of EdU-labeled 
individual chromosome territories (CTs), only present in 
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cells that underwent several rounds of mitotic division 
[20, 21], and of micronuclei and giant nuclei, hallmarks 
of genomic instability [22]. Of note, nuclei displaying 
EdU-labeled CTs, giant nuclei and micronuclei may 
concur within the same cell. At low EdU concentrations 
(5 and 10 µM), a significant fraction (> 80%) of labeled 
nuclei shows individual CTs consistent with continued 
cell division (Figure 1A). However, the presence of cells 
harboring micronuclei (19.4 ± 1.6% and 36.5 ± 5.9% for 5 
and 10 µM EdU, respectively) and giant nuclei (8.8 ± 2.7% 
and 16.2 ± 3.5% for 5 and 10 µM EdU, respectively) 
were noticeably higher than in EdU-negative controls 
(5.9 ± 1.9% for micronuclei and 1.6 ± 0.7% for giant 
nuclei) (Figure 1A). At 30 µM, EdU induced a drastic 
reduction of CTs (only 11.3 ± 4.3% of positive cells) and 
a sharp increase in cells with signs of genomic instability 
(micronuclei: 31.9 ± 4.3%; giant nuclei: 64.3 ± 9.7%). 
These data indicate that in the long-term EdU induces overt 
signs of genomic instability.
Since the novel approach proposed here does not 
require long exposures to EdU, we next tested whether 
pulsing HCT-116 cells with EdU (2.5, 5, 10 and 20 µM) 
for a short period (11 h) induced DNA damage in the form 
of DNA breaks and replication stress; negative controls 
were provided by cells exposed to solvent alone. Testing 
the presence of DNA breaks (single- and double-stranded) 
by alkaline single-cell gel electrophoresis (comet assay) 
revealed that EdU induced statistically significant, though 
modest (tail moments less than twice background), levels 
of DNA breaks (Figure 1B, also cf. Supplementary Figure 1 
in Supplementary Data for percentage of DNA in comet 
tails). By contrast, camptothecin (CPT; 5 µM), a known 
inducer of DNA breaks, and CPT plus EdU (20 µM) 
induced more significant amounts of DNA breakage, as 
expected. To specifically check for the presence of EdU-
induced DNA double-stranded breaks (DSBs), HCT-116 
cells were immunostained for histone γH2AX (variant 
histone H2AX phosphorylated on serine 139), known to 
accumulate as nuclear foci at genomic sites harboring 
DSBs [23]. Enumeration of γH2AX foci showed that EdU 
at 20 µM induced a significant increase in damage foci 
(average of 12 foci per cell; Figure 1C). Although γH2AX 
DNA damage foci still increased significantly after a 
11 h exposure to 5 and 10 µM EdU (3 foci per cell on 
average), this increase was only twice background levels, 
becoming non-significantly different from control levels at 
2.5 µM (Figure 1C). Moreover, nuclear foci concentrating 
phospho-RPA (Replication protein A), indicative of 
replicative stress, were not increased in HCT-116 cells 
exposed to EdU 2.5, 5, 10 or 20 µM for 11 h (Figure 1D). 
In accordance, western blotting analysis for the presence 
of increased levels of phospho-RPA and γH2AX after short 
term exposures to EdU (11 h; 10 and 20 µM) did not show 
any noticeable difference relative to EdU-less controls; 
however, as anticipated, cells treated with CPT (plus/
minus 20 µM EdU) displayed high levels of both phospho-
RPA and γH2AX (Figure 1E). Importantly, exposure of 
different cell types namely HCT-116, mouse embryonic 
fibroblasts (MEFs), and mouse embryonic stem cells 
(mESCs) to EdU (10, 5 and 2.5 µM, respectively; 11 h) did 
not change cell cycle profiles obtained by flow cytometry 
(propidium iodide/PI and 4',6-diamidino-2-phenylindole/ 
DAPI staining; Figure 1F). These data are consistent with 
DNA damage and replication stress sensitive checkpoints 
not being activated within this timeframe.
Altogether, these results show that in the long-term 
(5 days) even low doses of EdU induce prominent signs 
of genomic instability and alterations in cell division, in 
line with previously reported genotoxic effects of EdU 
[19, 24]. However, short term exposures (11 to 12 h) to 
low concentrations of EdU (2.5 to 10 µM) can conciliate 
with unperturbed cell cycle progression and thus be used 
in subsequent analyses. 
Stoichiometry of detection of EdU-labeled DNA 
Herein, we aimed at developing a novel methodology 
for extracting absolute values (i.e. in units of time) on the 
duration of S phase through the analysis of fluorescence 
intensities of EdU incorporated into replicating DNA 
(EdU-DNA). To do so, we first assessed whether detection 
of EdU-DNA followed strict stoichiometry. Incorporation 
of different concentrations of EdU (0, 5, 10, 15, 20 and 
30 µM) into cultured HCT-116 cells for a defined period of 
time (9 h) showed that, as expected, emitted fluorescence 
intensities were not proportional to EdU concentrations 
(Figure 2A). However, for a defined concentration of 
EdU (10 µM), incorporation for incremental periods of 
time (1 h increments) from 0 h to 11 h revealed robust 
stoichiometry. Indeed, increasing periods of incorporation 
correlated linearly with increased amounts of total 
fluorescence, expressed as an integral, within the cell 
populations (Figure 2B). 
Finally, HCT-116 cells synchronized at G1/S 
transition by a double-thymidine block were released 
into S phase and allowed to incorporate EdU (10 µM) 
continuously for 7 h to achieve full-S labeling before 
harvesting. Cells were then collected first in G2/M phase 
(8 h after release from thymidine) and later when emerging 
in G1 phase of the next cell cycle (11 h after release). As 
quality controls for synchronization, analysis by flow 
cytometry (PI staining) revealed that after release from 
G1/S most cells progressed with remarkable synchrony 
(Figure 2C). Also, more than 80% of the metaphase 
spreads obtained from cells incorporating EdU for 7 h after 
release from the G1/S block displayed fluorescent labeling 
of EdU-DNA across the entire length of chromosome 
arms; this is consistent with full S labeling. In contrast, a 
partial (banded) EdU staining pattern was seen when cells 
were only briefly pulsed with EdU (10 min, 15 µM) at 
2.5 h or 4 h post release from thymidine (Supplementary 
Figure 2 in Supplementary Data). We then compared the 
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Figure 1: Effects of EdU on genomic instability, DNA damage and cell cycle progression. (A) Synchronized HCT-116 cells 
exposed for a single full S phase (7 h) to different concentrations of EdU (5, 10, 20 and 30 µM; controls exposed to solvent/DMSO alone) 
and analyzed 5 days later for the presence of chromosome territories, micronuclei and giant nuclei. Note that chromosome territories 
cannot be formally assessed in controls not exposed to EdU. (B) HCT-116 cells exposed for 11 h to EdU (2.5, 5, 10 and 20 µM; negative 
controls exposed to DMSO) or CPT (positive control; +/– EdU 20 µM) and analyzed by alkaline single-cell gel electrophoresis (comet 
assay; parameter: tail moment). (C) HCT-116 exposed to EdU (11 h) as above and analyzed for the presence of γH2AX nuclear foci by 
immunofluorescence. (D) HCT-116 exposed to EdU (11 h) or CPT (+/– EdU 20 µM) as above and analyzed by immunofluorescence for the 
presence of nuclear foci concentrating RPA. (E) Western blots of cells exposed to EdU (11 h; +/- CPT; negative controls exposed to DMSO) 
and probed for phospho-RPA, RPA, γH2AX and H2AX. H2AX provides loading controls. (F) Flow cytometry histograms of HCT-116 cells 
and mESCs (PI staining), and MEFs (DAPI staining) either exposed to EdU for 11 h (HCT-116: 10 µM; mESCs: 2.5 µM; MEFs: 5 µM; 
blue) or not (controls; red). Results for all figures are presented as mean + SD; ***p <  0.001; **p <  0.01; ns: p > 0.05. 
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intensities of EdU-coupled fluorescence between cells 
labeled for a full S phase and collected at G2/M stages 
(DNA = 4n) with those allowed to progress into G1 stage 
(DNA = 2n). This revealed that appearance of G1 cells 
harboring half the amount of EdU-DNA coincided with 
the emergence of a half-intensity peak (mean fluorescence 
intensity (MFI) of the G2/M peak and the G1 peak are, 
respectively, 443 and 212; Figure 2C).
In all, these data showed a strict correspondence 
between amounts of EdU-substituted DNA and intensities 
of EdU-coupled fluorescence and predicated our 
subsequent use of EdU in experiments aimed at estimating 
accurate cell cycle parameters.
Analysis of EdU-coupled fluorescence intensities
In the approach proposed here it is assumed that 
exposing asynchronously growing cell populations to EdU 
for incremental periods of time the maximum labeling 
intensity of EdU-DNA should be reached when the pulsing 
Figure 2: Stoichiometry of detection of EdU-labeled DNA. (A) HCT-116 cells were exposed to different concentrations of EdU 
(5, 10, 15, 20 and 30 µM) or DMSO (controls) for 9 h followed by detection of EdU-DNA by Click-iT chemistry (Alexa Fluor 488). 
(B) HCT-116 cells exposed to a fixed concentration of EdU (10 µM) for incremental periods of time (1 to 11 h; 1 h increments) before 
detection of EdU-DNA by Click-iT chemistry. Results are expressed as an integral (sum of fluorescence intensities above background 
levels) for each time point. (C) Synchronized HCT-116 cells were allowed to incorporate EdU for a single full S phase and collected while 
traversing G2 stage, and later after passage into G1 stage of the next cell cycle. Histograms from cells stained for EdU-DNA (Click-iT; 
Alexa 488; green) and bulk DNA (PI staining; red) are depicted. Note that the EdU-coupled fluorescence peak of G1-synchronized cells 
(MFI: 212) has ≈48% of the intensity of the peak resulting from G2-synchronized cells (MFI: 443).
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times approach, or equal, the duration of S phase. For such 
pulsing times, the cohort of cells in which the beginning of 
the pulse coincides with initiation of S phase shall become 
labeled for a full S phase and shall thus feature maximal 
labeling intensity. Absolute length of S phase shall then be 
equivalent to the minimum pulsing period with EdU that 
is required to achieve maximal EdU-coupled fluorescence 
intensity. Thereafter, increments in pulsing periods are 
expected to just increase the fraction of cells showing 
maximal labeling (Figure 3).
To test this idea, parallel cultures of colon cancer 
cells (HCT-116) were pulsed with EdU for incremental 
periods from 1 h to 11 h (1 h increments). Fluorescent 
detection of EdU-DNA was performed utilizing an azide-
coupled fluorophore (Alexa 488) as part of Click-iT 
chemistry (cf. Materials and Methods) and bulk DNA was 
stained with either PI or DAPI. These experiments showed 
that fluorescence intensities associated with EdU-DNA 
increase steadily with increasing pulsing times (Figure 4; 
x axis represents fluorescence intensities). Maximal 
fluorescence intensities were first reached between 6 h 
and 7 h of continuous incorporation of EdU (Figure 4, 
7 h time point, peak 3; MFI: 2677). According to our 
hypothesis this should be consistent with S phase duration 
of 6–7 h, indeed in good agreement with data obtained 
for HCT-116 cells using established methods of cell cycle 
analysis (cf. Table 1). To estimate the duration of S phase 
by E-CFI with higher temporal resolution (n = 10) HCT-
116 cells were exposed for 6 to 8 h to EdU (10 µM) using 
pulsing increments of 30 min (i.e., 6, 6.5, 7, 7.5 and 8 h). 
This provided a more refined appraisal for S phase length 
(6.80 ± 0.35 h; Table 1). As expected, longer pulses 
with 10 µM EdU (8 h to 11 h) resulted in no discernible 
increment in maximal fluorescence intensities (Figure 4). 
However, these longer pulsing times led to an increase in 
the height, i.e. number of events/EdU-labeled cells (y axis), 
of the peak corresponding to the maximally labeled cell 
population (peak 3 in Figure 4). This is also anticipated 
given the higher chance for maximal (full S) labeling by 
increasing pulsing periods with EdU (Figure 3). 
We then assessed whether the minimum pulsing time 
with EdU required for achieving maximal fluorescence 
intensity of EdU-DNA, assumed here to correspond to 
S phase length, indeed corresponds to incorporation of 
EdU for a single, full S phase. To do so, exposure to EdU 
was restricted to a single S phase by blocking cell cycle 
progression in G2 stage with the Cdk1 inhibitor RO-
3306. Asynchronous HCT-116 cultures were thus exposed 
simultaneously to EdU (10 µM) and to RO-3306 (10 µM) 
for 5, 7, 9 and 16 h. Controls were provided by parallel 
cultures exposed to EdU alone for identical periods of 
time and by cells not exposed to EdU (solvent alone). This 
experimental design ensures that a substantial fraction of 
cells (≈24%), i.e. those that were traversing G1 stage upon 
addition of EdU, will incorporate EdU for a full (and single) 
S phase and will not progress into the next cell cycle. 
As seen in the cell cycle histograms for bulk DNA 
staining (PI), after addition of the Cdk1 inhibitor the cell 
population initially in G1 stage progressively disappears 
before cells finally arrest in G2 stage, as expected 
(Figure 5). Analysis of EdU-coupled fluorescence 
further showed that maximal fluorescence intensities of 
EdU-DNA overlapped irrespectively of the presence of 
RO-3306 (Figure 5). 
Figure 3: EdU-coupled Fluorescence Intensity analysis - the principle. Arrows represent pulsing times of different lengths 
with EdU. Fluorescence intensities are denoted by thickness of arrows. Note that cells in asynchronous populations are placed at any of 
many possible positions of the cell cycle upon exposure to the EdU pulse. Duration of S phase is probed by pulsing cells with EdU for 
defined, incremental periods of time. When pulsing times match the duration of S phase the cohort of cells that, by chance, at the beginning 
of the pulse are initiating S phase will incorporate EdU for a full S phase. This cell population shall thus feature maximal EdU-coupled 
fluorescence intensity. Increasing pulsing times beyond the duration of S phase shall not increase maximal fluorescence intensities but just 
the percentage of cells displaying intensity maxima. Duration of S phase is thus estimated from the minimal pulsing time with EdU that 
elicits emergence of a population featuring maximal fluorescence intensity. Clearly, pulsing times shorter than S phase length shall not 
allow reaching maximal intensities. In this assay the time variable is introduced by pulsing times of defined duration and the key parameter 
is fluorescence intensity, not the fraction of labeled cells. 
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These data strongly support the notion that the 
intensity maxima seen in our initial founder experiments 
indeed correspond to labeling for a full, single S phase 
(Figure 4). Importantly, the length of S phase estimated 
here by flow cytometric analyses of intensity maxima of 
EdU-coupled fluorescence is in excellent agreement with 
data obtained for HCT-116 cells utilizing other, previously 
validated methodologies (cf. Table 1 and text further 
below in this section). 
Exploiting other EdU-coupled fluorescence 
intensity peaks 
We initially focused on a  sub-maximum intensity 
peak that in HCT-116 cells is evident after 9 h of EdU 
incorporation and becomes increasingly prominent 
thereafter (Figure 4, peak 4).  Use of the Cdk1 inhibitor 
RO-3306 allowed elucidation of the nature of this intensity 
peak. When cells are blocked in their progression into the 
Figure 4: Estimation of S phase duration. HCT-116 cells were exposed to EdU (10 µM) for 1 to 11 h (1 h increments) followed 
by detection of EdU-DNA by Click-iT chemistry (Alexa 488) and analysis by flow cytometry. EdU-coupled fluorescence intensities are 
displayed along the x axis in logarithmic scale. Arrowheads denote the mean fluorescence intensity (MFI) reached by maximally labeled 
cell populations that incorporated EdU for a full S phase (peak 3; MFI: 2677). Background peaks 1 and 2 correspond to, respectively, G1 
and G2 cells that have not yet incorporated EdU. Note that peak 4 stemming from maximally labeled cells that reached G1 stage of the 
subsequent cell cycle features ≈1/2 the mean intensity of peak 3 (MFI: 1430, ≈53% of peak 3). Histograms are representative of one out of 
twelve independent experiments. Minimum number of analyzed events was 30000 per time point. 
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subsequent G1 phase by RO-3306 this peak is absent 
(Figure 5, 9 h and 16 h, peak 4). Importantly, the mean 
fluorescence intensity of this accessory peak is half the 
intensity of the maximally (full S) labeled cell population 
(MFI of peak 4 and peak 3 are, correspondingly, 345 and 
671). Moreover, in control cells (RO-3306-minus) that 
progressed unperturbed for 16 h to G1 stage of the next 
cell cycle, this peak became the most prominent (Figure 5, 
peak 4). Together, these data implicate this half-maximum 
intensity peak as originating from G1 cells that resulted 
from the mitotic division of full-S-labeled cells. Since 
these G1 cells harbor half the amount of EdU-DNA as 
their progenitors and, correspondingly, emitted half the 
mean fluorescence intensity, this further confirms the good 
stoichiometric properties of the EdU detection system. 
Careful analysis of the EdU incorporation histograms 
depicted in Figure 4 reveals the consistent presence of 
additional, lower intensity peaks of fluorescence that 
change over time; of note, these peaks are already present 
in cells not exposed to EdU (No-EdU control; cf. Figure 4). 
Interestingly, the lower intensity background peaks seen 
in this EdU-negative population, likely due to the non-
specific binding of the azide-Alexa 488 to bulk DNA, 
decomposed in two peaks after exposure to EdU even 
for short periods (Figure 4, peaks 1 and 2). Indeed, 
dual parameter analyses (EdU-coupled fluorescence vs 
total DNA/PI) showed that these two remaining peaks 
corresponded, respectively, to cells with G1 DNA content 
(2n; lower intensity peak) and G2 DNA content (4n; 
higher intensity peak) (Figure 6A). Cells with intermediate 
DNA contents (2n to 4n; S population), contributing 
to intermediate background intensities, have shifted 
to higher intensity regions upon incorporation of EdU 
leaving behind the double-peak (G1+G2) configuration 
of the background staining (Figure 6A, peaks 1 and 2). 
We note that background peaks do not always present the 
double-peak configuration. However, these peaks were 
consistently present in the many experiments performed 
Table 1: Comparison of estimates for cell cycle phase length obtained for HCT-116 DNA-PK WT 
and HCT-116 DNA-PK KO through different methodologies
HCT-116 DNA-PK WT
Method G1 G2 G1 + G2 S Tc
EdU-coupled Fluorescence Intensity 
(E-CFI)*
5.4 ± 0.95 h 3.8 ± 0.45 h 6.8 ± 0.35 h 16.00 ± 1.04 h
Fraction of Labeled Mitotic cells (FLM) 4.39 ± 0.01 h 6.75 ± 0.03 h
Cumulative Labeling 
≈7.5 h 
(EdU+ cells: 
97.6 ± 1.8%)
Leaving Fraction 6.3 ± 0.4 h
EdU pulse-chase 5.4 ± 0.55 h 6.2 ± 1.3 h
DNA Content (Dean Jett Fox cell cycle 
algorithm)**
4.8 ± 0.7 h 3.9 ± 0.6 h 5 ± 1.2 h
DNA Content (Watson Pragmatic cell cycle 
algorithm)**
4.3 ± 0.6 h 4.1 ± 2.5 h 6.7 ± 2 h
HCT-116 DNA-PK KO
Method G1 G2 G1+G2 S Tc
EdU-coupled Fluorescence Intensity 
(E-CFI)*
6.0 ± 1.45 h 3.6 ± 0.55 h 6.75 ± 0.42 h 16.35  ± 1.54 h
Fraction of Labeled Mitotic cells (FLM) 4.4 ± 0.03 h 6.76 ± 0.02 h
Cumulative Labeling
≈9 h 
(EdU+ cells: 
94.6 ± 2.8%)
EdU pulse-chase 4.75 ± 0.5 h 7.25 ± 0.5 h
*Tc (Total length of cell cycle) was estimated by standard error propagation; duration of S phase was estimated as the first 
pulsing time with EdU after which maximal EdU-coupled fluorescence intensities clustered within 2 SDs from each other. 
**Estimated cell phase durations are derived from the percentage of cells in each cell cycle stage calculated using cell cycle 
analysis algorithms within FlowJo software, assuming a total cell cycle length of 15 h. 
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here, acting as robust markers for the EdU-negative G1 and 
G2 populations. As expected, under continuous exposure 
to EdU these G1/G2 background peaks progressively 
disappear as cells initially at G1 and G2 stages move 
steadily into S phase and acquire strongly fluorescent EdU-
coupled signals (Figure 4). We reasoned that the dynamics 
of these G1/G2 background peaks during time-course 
experiments may reflect the absolute lengths of G1 and G2 
stages. The duration of G2 stage shall therefore correspond 
to the period of time during which cells with G2 DNA 
content (4n) persist featuring background staining. Since 
this cohort of G2 cells feeds into the next G1 phase, the 
duration of G1 shall be estimated after subtracting the 
length of G2 phase from the total duration of the G1 (2n) 
background peak. 
We then utilized dual parameter analysis (EdU-
coupled fluorescence vs total DNA/PI) to monitor over 
time the dynamics of G1 and G2 cell populations that are 
EdU-unlabeled, i.e. just featuring non-specific background 
staining. As shown in Figure 6B (n = 5) the percentage 
of G2 cells in the whole population steeply declined over 
time, reaching baseline levels after ≈4 h of exposure to 
EdU (G2 length: 3.8 ± 0.45 h; Table 1). After an initial 
plateau, the percentage of G1 cells decreased until 8–9 h 
of EdU incorporation followed by a smoother decline 
afterwards (Figure 6B). The initial plateau highlights 
the exit of G1 cells into S phase being compensated by 
entry into G1 stage of cells from the preceding G2 phase; 
the slower decline after the 8 h time point underscores 
the further existence of a minor population in the 
G1 compartment (< 5%) comprised of slow-(or non-)
cycling cells . The length for G1 phase (5.40 ± 0.95 h) 
was estimated as the duration of G2 subtracted from the 
time for decline of the whole G1 population to baseline 
levels; this provided a good match to data gathered using 
validated methods (Table 1).
To further test the sensitivity of this approach we 
introduced in our analyses HCT-116 cells that are deficient 
(knock-out/KO) for the DNA repair enzyme DNA-
dependent Protein Kinase (DNA-PK; HCT-116 DNA-PK 
KO). Using the EdU-pulsing method described herein 
(E-CFI) HCT-116 DNA-PK KO cells reached maximum 
EdU-coupled fluorescence intensity after ≈7 h of EdU 
incorporation (Supplementary Figure 3 in Supplementary 
Data). As previously performed for HCT-116 (DNA-PK wt) 
cells, short (30 min) increments in EdU pulsing between 
6 and 8 h allowed a more accurate estimate for S phase 
length in  HCT-116 DNA-PK KO cells (6.75 ± 0.42 h; 
n = 6; Table 1). This value is similar to that obtained 
for the DNA-PK proficient (wt) HCT-116 cells used 
throughout this research, and was confirmed by previously 
validated methodologies (Table 1). 
We subsequently tested in HCT-116 DNA-PK KO 
cells, as described above for HCT-116 cells, whether 
quantitative analysis of G1/G2 background peaks again 
provided accurate values for the lengths of G1 and G2 
phases.  Analysis of five independent experiments showed 
that the percentage of G2 cells sharply decreased over 
4 h of EdU incorporation before reaching baseline levels 
(Figure 6C). This is consistent with a G2 phase length 
(3.60 ± 0.55 h; n = 5) in HCT-116 DNA-PK KO cells that 
is similar to HCT-116 cells that are proficient for DNA-PK 
Figure 5: Intensity maxima of EdU-coupled fluorescence correspond to labeling for a single full S phase. Asynchronous 
HCT-116 cells pulsed with EdU (10 µM) +/– Cdk inhibitor (RO-3306; 10 µM) and collected at defined time points (5, 7, 9 and 16 h) were 
analyzed by flow cytometry. Detection of EdU-DNA was done with Click-iT chemistry (Alexa 488; green) and total DNA was stained 
with PI (red). Fluorescence peak 1 corresponds to G1 background; peak 2 to G2 background; peak 3 to maximal intensity coupled to cells 
maximally labeled for EdU-DNA (MFI: 671); and peak 4 to half-maximal intensity associated to cells that reached G1 stage of the next cell 
cycle (RO-3306-minus group, MFI: 345). Note that maximal fluorescence intensities are similar irrespectively of the presence of RO-3306, 
and that peak 4 is absent from cells arrested in G2 by RO-3306.
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(Table 1). However, the decline in G1 cells lasted longer in 
DNA-PK KO cells than in their DNA-PK-wt counterparts. 
Near-baseline levels were reached at 9 h, with a slower 
decline thereafter (Figure 6C). After subtracting the 
duration of G2 this yields a length for G1 phase that is 
slightly higher (6.0 ± 1.45 h; n = 5) for DNA-PK KO than 
for DNA-PK wt HCT-116 cells (Table 1).  Note that the 
fraction of slow/non-cycling cells (between 5 and 10%) is 
clearly more prominent than in HCT-116 cells harboring 
wt DNA-PK (< 5%) (Figures 6B and 6C). Indeed, the 
fraction of slow/non-cycling cells which do not incorporate 
modified deoxy-nucleosides even after prolonged exposure 
times was also shown to be higher in HCT-116 DNA-
PK KO cells using other methods of cell cycle analysis 
(Figures 8C and 8D).
In sum, these data highlight the relevance of 
analyzing other peaks present in EdU-coupled fluorescence 
intensity histograms. Specifically, it was shown that 
Figure 6: Identity of background intensity peaks. (A) HCT-116 cells exposed for 1 h to EdU (10 µM) were stained for EdU-DNA 
(Click-iT; Alexa 488; green) and total DNA (PI) and subjected to dual-parameter processing (EdU vs total DNA). Gating for G1 and G2 
populations and superimposing their fluorescence profiles with those of the entire cell population reveals the identity of the two background 
peaks. Note that the G1 peak (red frame) overlaps with background peak 1 and that the G2 peak (blue frame) overlaps with background 
peak 2. (B) HCT-116 cells were exposed to EdU (10 µM) for incremental pulsing times (1–10 h) according to the E-CFI protocol. The 
corresponding background peaks were decomposed in their constituent G1 (red line) and G2 (blue line) populations which were quantified 
over time. Data shown are from 5 independent experiments. (C) HCT-116 cells (DNA-PK KO) and the corresponding background peaks 
were processed as above for DNA-PK wt HCT-116 cells. Data shown are from 4 independent experiments. Results in B and C are presented 
as mean + SD.
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quantitation of background intensity peaks provides 
accurate measurements for the lengths of G1 and G2 
phases. These low intensity peaks also allow quantitative 
estimates of slow/non-cycling cells within a population.
EdU-coupled fluorescence intensity analysis in 
non-transformed mouse cells
We next tested whether the analysis of fluorescence 
intensities associated with EdU-DNA could be applied to 
accurately judge cell cycle parameters in other cell types, 
namely in non-transformed cells. To this end, we utilized 
pre-quiescent (passage 26–28) mouse embryonic fibroblasts 
(MEFs) and mouse embryonic stem cells (mESCs). These 
cell types were chosen for their remarkably different 
duplication times. Pre-quiescent MEFs duplicate over a 
period of days, with a large proportion of cells in G1 and 
G2 stages (Figure 1F). By contrast, when under logarithmic 
growth mESCs feature a short cell cycle length with fast 
gap and S phases [25]. Given the exquisite sensitivity 
of ESCs to EdU [26], in this set of experiments we have 
consistently used lower doses of EdU (2.5 and 5 µM). 
MEFs and mESCs were therefore exposed for 
increasing periods of time (0 to 11 h; 1 h increments) to 
EdU (MEFs/5 µM; mESCs/2.5 µM) before analysis of 
EdU-DNA fluorescence intensities by flow cytometry, 
as previously described. This showed that MEFs reached 
maximal intensity after 8 h of continuous incorporation 
of EdU (Figure 7A). As expected for pre-quiescent cell 
populations with a long G1 phase, the G1/G2 background 
peaks remained remarkably stable over the incremental 
pulsing periods used here (Figure 7A plus data not shown). 
By contrast, mESCs displayed maximal intensity of EdU-
coupled fluorescence after just ≈5 h of exposure to EdU 
(Figure 7B; MFI: 60636). Also, in mESCs the G1/G2 
background peak decreased to residual levels after 
incorporation of EdU for 4 to 5 h (Figure 7B plus data 
not shown). Quantitative analysis of background peaks as 
performed above for HCT-116 cells showed that G1 and 
G2 phases lasted ≈2 h each (data not shown). These data 
are consistent with a total length of ≈9 h for the full cell 
cycle in mESCs, in excellent agreement with previously 
published data [25]. 
These experiments further extend the applicability 
of the novel E-CFI method to other cell types, even under 
the constraint of utilizing very low concentrations of EdU.
Comparison with other methods of cell cycle 
analysis
We subsequently tested how the method developed 
here compared to previously implemented assays aimed at 
estimating cell cycle parameters. 
In a robust pulse-chase method–termed “Fraction 
of Labeled Mitoses” - that allows absolute estimates of 
the duration of S and G2 phases, cells are first briefly 
pulsed with a radioactive or a modified deoxy-nucleoside 
(e.g. BrdU), chased in mitosis for incremental periods of 
time and scored for the presence of labeled chromosomes 
[13, 14, 27]. In this assay, the time between pulsing and 
the emergence of the first labeled mitotic cells (≈50% of 
labeled cells) equals the absolute duration of G2. The 
time period during which the cohort of cells previously 
labeled in S phase with BrdU continues showing up in 
mitosis with BrdU-labeled chromosomes corresponds to 
the absolute duration of S phase [14].
Parallel cultures of HCT-116 cells (DNA-PK wt and 
DNA-PK KO) were therefore pulsed with BrdU (20 µM; 
15 min), collected at hourly intervals up until 12 h after 
pulsing, immuno-stained for BrdU, and the percentage 
of BrdU positive mitotic cells (prometaphase plus 
metaphase stages) was assessed for each time point. These 
experiments showed values for S and G2 phases very close 
to those obtained using E-CFI, for both DNA-PK deficient 
and proficient HCT-116 cells (Figure 8A and Table 1).
We also used the “Leaving Fraction” method 
in which cells are first pulsed with a modified deoxy-
nucleoside, chased for a defined time period in medium free 
of modified nucleosides, and subjected to a second pulse 
with a differently modified nucleoside before collection (cf. 
Materials and Methods). The fraction of cells labeled by the 
first modified nucleoside but not by the second corresponds 
to the so-called leaving fraction, i.e. the fraction of cells 
that although initially in S phase have reached G2 during 
the chase period. Through extrapolation, the time required 
for all cells to leave S phase, which equals S phase 
duration, can be estimated as an absolute value (see also 
Materials and Methods) [28–30]. Notably, this microscopy-
based method also yielded an S phase duration (6.3 ± 0.4 h) 
similar to that we have obtained throughout this research 
for HCT-116 cells using E-CFI (Table 1).
In a third approach we used a “Cumulative 
Labeling” method, also known as “Saturation Labeling” 
[31], to assess the absolute duration of G1 plus G2 stages. 
The underlying principle is that upon a brief exposure to a 
modified deoxy-nucleoside this is exclusively incorporated 
into the replicating DNA of cells traversing S phase. 
However, if pulsing times are progressively extended to 
encompass the duration of G1 plus G2 all cells initially at 
these stages will ultimately be allowed to reach S phase and 
thus to incorporate the analogue. Therefore, the minimal 
pulsing times with the analogue that allow labeling of the 
whole cell population will match the combined duration of 
G1 plus G2 stages for that population [32, 33]. HCT-116 
cells (DNA-PK wt and DNA-PK KO) were thus pulsed 
with BrdU (10 µM) for incremental periods of time up 
until 10.5 h before scoring by fluorescence microscopy. 
Again, the estimates for the combined duration of G1 
plus G2 (HCT-116 DNA-PK wt: 7.5 to 9 h ; HCT-116 
DNA-PK KO: ≈9 h) closely agree for both cell lines with 
those obtained using E-CFI (Figure 8C, 8D and Table 1). 
Interestingly, for both cell lines a sub-population of slow-/
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non-cycling cells was identified that was slightly more 
prominent in DNA-PK KO cells, as previously seen in 
experiments using E-CFI (Figure 8C and 8D).
Additionally, we used a pulse-chase methodology 
for estimation of the lengths of S and G2 phases [19]. 
To this end, HCT-116 (DNA-PK wt and DNA-PK KO) 
and mESCs were pulsed with EdU (10 µM and 5 µM, 
respectively) for 30 min and collected either immediately 
(no chase), or else chased in EdU-free medium before 
collection at hourly intervals. The length of G2 phase was 
estimated as the period of time between the end of the EdU 
pulse and the time point at which the population harboring 
G2 DNA content (4n) showed the highest percentage of 
EdU-positive cells. This expectedly occurs when the cohort 
of EdU-labeled cells (i.e. in S phase during EdU pulsing) 
reaches the G2/M transition after traversal of G2 phase. 
The interval between this latter time point and the time 
point where the population with 4n DNA content reaches 
its lowest percentage of EdU-positive cells was considered 
as the duration of S phase. This corresponds to the period 
during which the cohort of EdU-labeled cells fully passes 
through the G2/M transition into the next G1 phase.
Analysis by dual-parameter flow cytometry (EdU vs 
total DNA/PI) showed that the cohorts of EdU-labeled vs 
unlabeled cells progress evenly over time between cellular 
compartments harboring 2n and 4n DNA amounts (HCT-
116 cells; Supplementary Figure 4 in Supplementary 
Data, plus data not shown). However, as depicted in 
Supplementary Figures 4 and 5 (Supplementary Data; 
HCT-116 cells), for each of four independent experiments 
it proved difficult to judge for cells with 4n DNA the 
time points at which the percentage of EdU-positive 
Figure 7: EdU-coupled fluorescence intensity analysis in non-transformed mouse cells. Arrowheads denote the mean 
fluorescence intensity (MFI) reached by maximally labeled cell populations that incorporated EdU for a full S phase. EdU-coupled 
fluorescence intensities are displayed along the x axis in logarithmic scale. (A) MEFs were pulsed with EdU (5 µM) for 1 to 11 h (1 h 
increments) followed by detection of EdU-DNA by Click-iT chemistry (Alexa 488) and analysis by flow cytometry. Only select pulsing 
times are shown. Note that maximal fluorescence intensity is reached at 7–8 h. (B) Mouse ESCs were pulsed with EdU (2.5 µM) and 
processed as above. Maximal fluorescence intensity is reached at 5 h.
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cells reached a maximum. Indeed, in these bowl-shaped 
curves these maximal values - typically reached at 4 to 
6 h after the EdU pulse - are almost identical between 
neighbor time points (cf. Supplementary Figure 5). When 
these data were combined (n = 4) in a single line chart 
this showed that the maximal percentages of EdU-positive 
cells (4n DNA) seen at the 4, 5 and 6 h time points were 
not significantly different (81.2 ± 12.3%, 86.6 ± 9.7%, 
86.4 ± 3.5%; 4, 5 and 6 h , respectively; Supplementary 
Figure 6A in Supplementary Data). Within the constraints 
of this method, we estimated the length of S and G2 phases 
for HCT-116 cells (DNA-PK wt, n = 5; DNA-PK KO, 
n = 4; Table 1).  These values, despite their lower temporal 
resolution in particular for S phase, are in broad agreement 
with those obtained by E-CFI (Table 1). Assessment of 
mESCs by EdU pulse-chasing yielded better homogeneity 
between different experiments as shown in the graph 
depicting pooled data (n = 4; Supplementary Figure 6B 
in Supplementary Data). The durations of S (5.75 ± 0.5 h) 
and G2 (4.25 ± 0.5 h) phases were estimated taking the 4 h 
time point as that corresponding to the highest percentage 
of EdU-positive cells within the 4n DNA population (cf. 
Supplementary Figure 6B in Supplementary Data).
Finally, we combined the commonly used analysis 
of the cell cycle by flow cytometry after PI staining of 
DNA with estimates of the absolute duration of the cell 
cycle in HCT-116 cells. This latter parameter is essential to 
convert the percentage of cells at a given cell cycle phase, 
which directly correlates with the relative length of that 
same phase in reference to the full cell cycle, into absolute 
lengths (i.e., in units of time). 
Taking the duration of the cell cycle as the absolute 
parameter (14–15 h for HCT-116 cells), the percentage 
of cells seen at each cell cycle stage in flow cytometry 
Figure 8: Comparison with other methods of cell cycle analysis. (A) Fraction of labelled mitoses, HCT-116 cells. Cells were 
briefly pulsed with BrdU (20 µM; 15 min) and collected hourly up until 12 h after pulsing. The fraction of BrdU-positive mitotic cells was 
assessed per time point. Three independent experiments were performed per time point, each scored in technical triplicates; a minimum of 
300 mitotic cells were counted per technical triplicate. (B) Fraction of labelled mitoses, HCT-116 DNA-PK KO cells. Cells were processed 
and scored as above for HCT-116 DNA-PK wt cells. Shown are results from three independent experiments. (C) Cumulative labeling, 
HCT-116 cells. Asynchronous HCT-116 cells were pulsed with BrdU (10 µM) for incremental periods (1.5 to 9 h; 1.5 h increments). Three 
independent experiments were performed per time point, each scored in technical triplicates; a minimum of 600 cells were counted per 
technical triplicate. (D) Cumulative labeling, HCT-116 DNA-PK KO cells. Cells were processed and scored exactly as in C, except that 
continuous pulsing with BrdU was extended to 10.5 h. Shown are results from three independent. All results are presented as mean + SD.
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histograms of PI-stained DNA was then converted into 
absolute lengths (hours). We note that the two available 
mathematical models within FlowJo, Watson Pragmatic 
(WP) and Dean/Jett/Fox (D/J/F), yielded discrepant 
percentages for each of the cell cycle stages in HCT-116 
cells. The values obtained through the WP algorithm 
provided a better fit to the data gathered throughout this 
research using different methodologies, including E-CFI 
(cf. Table 1, and Supplementary Table 1 in Supplementary 
Data). However, using either of these algorithms (WP 
or D/J/F) we could not generate any reliable estimates 
for the much less canonical cell cycle histograms from 
exponentially growing mESCs (depicted in Figure 1F). 
In sum, the E-CFI method described herein shows 
excellent concordance with data obtained through various 
well established methods of cell cycle analysis.
DISCUSSION
We have herein described an assay which we termed 
E-CFI that allows easy and accurate measurements of the 
absolute length of all stages of the cell cycle (G1, S and 
G2/M) by flow cytometry. 
The approach of reference to analyze the duration 
of the different stages of the cell cycle is based on flow 
cytometric analysis of cellular DNA stained with a 
fluorescent dye that binds stoichiometrically, and thus 
allows measurement of DNA content [34]. This provides 
values on the proportion of cells found at each phase (G1, S 
and G2/M) which directly correspond to relative durations 
in reference to the length of a full cell cycle. Despite the use 
of algorithms that attempt at fitting Gaussian curves to each 
phase, a clear distinction between cells traversing very early 
or late S phase from cells in G1 and G2 phase, respectively, 
remains difficult by single parameter DNA analysis [10, 34]. 
This difficulty becomes more obvious for cell types with 
atypical cell cycles namely with very long G1 phases, as 
is the case of pre-quiescent MEFs, or very short G1 and 
G2 phases, such as mESCs (Figure 1F; also Table 1). In 
such cases, under or overestimation of the length of S phase 
is the typical result [35]. Indeed, applying two different 
mathematical models, Dean/Jett/Fox and Watson Pragmatic, 
discrepant data was obtained for HCT-116 cells with D/J/F 
yielding unusually short durations for S phase (≈5 h; 
Table 1, and Supplementary Table 1 in Supplementary 
Data). Unfortunately, clear criteria for choice between 
different algorithms do not exist. In mESCs, in which S 
phase typically lasts more than 50% of the total cell cycle, 
both the D/J/F and the WP algorithms proved unreliable. 
Moreover, the conversion of these data on relative durations 
into absolute lengths for each phase requires an additional, 
accurate estimate of the absolute length of the cell cycle 
under the conditions being tested [7]. 
Pulse-chase methods utilizing EdU (or BrdU) also 
provide data on absolute durations of cell cycle phases and 
stand as possible contenders to the E-CFI assay described 
herein [19]. These methods, however, rely critically on 
selecting the fraction of EdU-positive cells within sub-
populations of defined DNA content. They therefore share 
the known constraints of quantitative analyses of single 
parameter DNA histograms [7, 36].  As a result, estimates 
for the duration of S and G2 stages have lower temporal 
resolution (higher dispersion) than those obtained with 
either E-CFI or other classical, validated methods (Table 1).
Herein, we have utilized pulse-chasing with EdU 
on HCT-116 cells (DNA-PK wt and DNA-PK KO) and 
mESCs, and found that the critical time points to judge the 
duration of G2 and S phase proved difficult to determine 
unambiguously. Setting up these time points allows tracking 
of the cohort of EdU-positive cells over time. These 
correspond, specifically, to the time point(s) at which the 
G2 (4n DNA) population features the highest percentage 
of EdU-positive cells and, later, the lowest percentage of 
EdU-positive cells.  The time interval between the end 
of the EdU pulse and the point(s) of maximal labeling 
corresponds to the length of G2; the interval between 
maximal and minimal labeling time point(s) corresponds to 
the length of S phase. 
The exemplary case is provided by mESCs 
(Supplementary Figure 6B in Supplementary Data). In 
these cells, the time points corresponding to maxima of 
EdU-positive cells (≈92% to ≈96%) distribute broadly 
between 2 and 5 h after pulsing with EdU, with the minimal 
fraction of EdU-positive cells seen at 10 h after pulsing 
(cf. Supplementary Figure 6B in Supplementary Data). 
Taking the 2 h time point as the most significant maximum 
would be consistent with a ≈2 h duration of G2 phase 
in mESCs, in agreement with previously published 
data and the results obtained herein using E-CFI [25]. 
However, the interval between this and the 10 h time point 
(minimal percentage of EdU-positive cells) would lead 
to an excessively long estimate for S phase (≈8 h). This 
dilemma stems, at least in part, from the duration of G2 
being much shorter than that of S phase, and also from 
the poor discrimination between cells at later stages of 
S phase (close-to-4n DNA) and genuine G2 cells. This 
latter issue can be appreciated at the end of the EdU pulse 
when most cells (> 60%) harboring 4n DNA content have 
indeed incorporated EdU (cf. Supplementary Figure 6B in 
Supplementary Data; 0 h after EdU pulse). 
The assay we describe here, E-CFI, is easy to perform 
and allows accurate estimates of absolute lengths (in units 
of time) of all the different stages of the cell cycle (G1, S, 
and G2/M). The duration of S phase is assessed without 
selection of cell populations based on DNA content. 
Although this is required for analysis of G1 and G2 phases, 
these two phases can be accurately separated given the 
absence of cells in the intervening S phase in background 
peaks. The classical problem of discriminating cells at the 
G1/S and S/G2 borders is thus avoided [7, 36]. Furthermore, 
E-CFI allowed the identification and quantification of sub-
populations with decreased proliferative potential (slow-/
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non-cycling cells) within the G1 compartment in HCT-116 
cells. We note that, in contrast to E-CFI, the duration of G1 
is difficult to quantify in dual-parameter histograms from 
EdU pulse-chase experiments (Supplementary Figure 4 in 
Supplementary Data). 
Herein, we have used the Cdk1 inhibitor (RO-3306) 
to demonstrate that the intensity maxima reached after 
continuous incorporation of EdU correspond indeed 
to labeling for a single, full S phase (Figure 5). These 
experiments further showed that E-CFI allows accurate 
estimation of S phase length even when cell cycle 
progression is blocked. Of note, this blockage would 
preclude the use of other methods of cell cycle analysis 
namely pulse-chase, cumulative labeling and methods in 
which labeled mitosis are scored.
E-CFI showed excellent correlation with the 
highly reproducible and precise methods of “Cumulative 
Labeling” and “Fraction-of-labeled mitosis/FLM” 
[15, 31–33] (Table 1). These microscopy-based classical 
methods are, however, highly time consuming and thus 
not amenable to routine use. By contrast, E-CFI yields fast 
results by acting in a time-compressing fashion whereby 
G1, S and G2/M phases are assessed in parallel. This 
allows absolute estimates on the lengths of each cell cycle 
stage to be collected over a time period that is shorter than 
the duration of a full cell cycle. For example, for HCT-116 
cells whose full cell cycle lasts for 15–16 h, the length of 
all cell cycle phases can be determined in 8–9 h.
We anticipate that E-CFI may provide a very 
valuable tool in the analysis of drugs targeting the cell 
cycle in the context of cancer chemotherapy, especially 
if coupled to powerful multiparametric analyses using 
flow cytometry or high-content imaging [7, 37, 36, 38]. 
Also, the basic principle that predicated the development 
of E-CFI may be applied in the future to quantitative 
fluorescence microscopy-based approaches aimed at 
estimating absolute, accurate cell cycle parameters.
MATERIALS AND METHODS
Cell culture, chemicals and antibodies 
Human colorectal carcinoma HCT-116 (ATCC CCL-
247) and HCT-116 knock-out for DNA-PK were obtained 
from the laboratory of Dr. Bert Vogelstein, Johns Hopkins 
School of Medicine, Baltimore, MD. HCT-116 cells were 
cultured in McCoy’s 5A Modified medium supplemented 
with 10% heat inactivated foetal bovine serum (FBS), 2 mM 
L-glutamine, 10mM MEM non-essential amino acids,  and 
100 U/ml penicillin/streptomycin (all from Gibco, Thermo-
Fisher Scientific, Waltham, MA, USA) and maintained 
at 37°C in a humidified incubator at 5% CO2. Mouse 
embryonic fibroblasts (MEFs) were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 
10% ES Cell-qualified FBS (Invitrogen, Thermo-Fisher 
Scientific, Waltham, MA, USA), 10 mM MEM non-
essential amino acids, and 0.1 mM 2-mercaptoethanol 
(Gibco).  Mouse embryonic stem cells (mESCs) were 
grown at 37°C in 5% CO2, in Glasgow Modified Eagle´s 
Medium (GMEM, Invitrogen) supplemented with 10% 
FBS (ES-Cell qualified), 10 mM MEM non-essential 
amino acids, 1% GlutaMAX, 1 mM 2-mercaptoethanol 
and 2 ng/mL Recombinant Human Leukemia Inhibitory 
Factor (LIF; serum/LIF conditions), on gelatin-coated 
(0.1% v/v) dishes (Nunc, Roskilde, Denmark). Cells were 
passaged on alternate days at a constant plating density of 
≈3 × 104 cells/cm2.
Camptothecin, RO-3306, 5-bromo-2´-deoxyuridine 
(BrdU), thymidine, propidium iodide (PI), 4’,6-diamidino-
2-phenylindole (DAPI) and RNase A were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). 
The following antibodies were used in this research: 
rabbit polyclonal to histone H2A.X (ab11175, Abcam, UK 
[39]), mouse monoclonal IgG1 to phospho-histone H2A.X 
(Ser139; clone JBW 301; Merck-Millipore, Darmstadt, 
Germany [40]), mouse monoclonal IgG1 to RPA32/RPA2 
(clone 9H8; ab2175 Abcam, UK [41]), affinity-purified 
rabbit polyclonal to phospho-RPA32/RPA2 (Ser4/Ser8; 
Cat. A300-245A; Bethyl Laboratories, Montgomery, 
TX, USA [42]), mouse monoclonal antibodies to BrdU 
(clones BU-33 and BMC 9318; Sigma-Aldrich), affinity-
purified Alexa 488-conjugated and Cy3-conjugated anti-
mouse secondary antibodies (Jackson ImmunoResearch 
Laboratories, Sacramento, CA, USA), and peroxidase-
conjugated affinity-purified goat anti-mouse IgG and goat 
anti-rabbit IgG (BioRad Laboratories, Hercules, CA, USA). 
EdU incorporation and detection for flow 
cytometry
EdU (5-ethynyl-2′-deoxyuridine), supplied with 
Click-iT EdU Alexa Fluor 488 Imaging Kit (#C10337, 
Thermo-Fisher Scientific, Waltham, MA, USA), was 
diluted in DMSO to a final concentration of 10 mM 
and kept at –20oC. Typically, EdU was added to parallel 
cultures growing exponentially in 30 cm2 petri dishes to 
final concentrations ranging from 2.5 to 30 µM for varying 
lengths of time until collection. Cells exposed to DMSO 
(solvent) alone served as controls. Cell pellets (approx. 
5 × 105 cells) were vigorously resuspended in 200 µL of 
ice cold 2% formaldehyde in PBS and fixed for 2 min, 
permeabilized by subsequent addition of 1 mL of 70% ice-
cold ethanol (without removal of formaldehyde), and kept 
on ice for a minimum of 10 min. Cells were then washed 
three times in 1 mL PBS containing 0.05% Triton X-100 
(PBS-Tx) before detection of EdU-substituted DNA (EdU-
DNA). Detection of EdU-DNA was performed according 
to the Click-iT EdU Alexa Fluor 488 Imaging Kit as per 
manufacturer’s instructions. Cell pellets were incubated 
in 100 µl of reaction buffer for 35 min at 37°C protected 
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from light. Cells were subsequently washed 4 × 10 min 
in 1 mL PBS-Tx 0.05% under constant shaking before 
staining of bulk DNA with PI or DAPI.
For PI staining, cell pellets were resuspended in 
300 µL of a solution comprised of 10 µg/mL PI, 192 µg/mL 
RNase A and 0.1% Triton X-100 in PBS and incubated 
for 30 min on ice, followed by a further incubation for 
30 min at 37°C, protected from light.  For DAPI staining, 
cell pellets were resuspended in a solution of 1 µg/mL of 
DAPI in PBS containing 0.1% TritonX-100 and incubated 
protected from light for 1h at 37°C. Cells were washed 
three times in PBS-Tx before measuring their fluorescence 
by flow cytometry. 
Flow cytometry instrumentation and data 
analysis 
Samples stained for EdU, PI and DAPI were 
analyzed using a three laser (blue-488 nm; red-640 nm; 
violet-605 nm) BD LSR Fortessa flow cytometer (BD 
Biosciences, San Jose, CA). EdU–Alexa 488 and PI 
signals were measured upon excitation by the blue laser 
using 530/30 and 695/40 bandpass filters, respectively. 
DAPI signals were measured upon excitation by the violet 
laser with the 525/50 bandpass filter. A minimum of 30000 
events were acquired per experiment in slow rate mode to 
avoid doublets.  Sample measurements were performed 
with FACSDiva Software (Version 6.2, BD Biosciences, 
San Jose, CA, USA). Data analysis, such as mean 
fluorescence intensity (MFI) measurements, was performed 
with FlowJo Software (Ashland, OR, USA). Cell debris 
and aggregates were excluded from the analysis using pulse 
processing FSC-A vs FSC-H, FSC-H vs FSC-W, SSC-H vs 
SSC-W, and FL2-A vs Fl2-W when appropriate. 
Immunofluorescence staining 
For immunofluorescence analysis, HCT-116 cells 
growing on coverslips were routinely fixed in freshly 
prepared 3.7% paraformaldehyde in HPEM buffer 
(30 mM HEPES, 65 mM Pipes, 10 mM EGTA, 2 mM 
MgCl2 (pH 6.9)) plus 0.5% Triton X-100 for 10 min at 
room temperature before incubation with antibodies. All 
washes were performed with PBS containing 0.05% Triton 
X-100. For detection of BrdU incorporated into replicating 
DNA, fixed cells were further incubated with 4N HCl for 
10 min to depurinate DNA and washed four times for 
10 min in Tris 50 mM (pH 8) preceding incubation with 
anti-BrdU antibodies. For the double labeling of BrdU 
and EdU immunostaining of BrdU preceded detection 
of EdU by the Click-iT method. Antibodies used for 
immunofluorescence were diluted in PBS containing 
fish skin gelatin (0.1%) and Triton X-100 (0.05%) as 
follows: anti-RPA32/RPA2 at 1/200, anti-phospho-histone 
H2A.X (Ser139) at 1/300, anti-BrdU at 1/100 and Cy3-
conjugated anti-mouse secondary antibodies at 1/100. 
After immunolabeling, total DNA was stained with DAPI 
(0.5 μg/mL) and coverslips were mounted in Vectashield 
(Vector Laboratories Inc., Burlingame, CA, USA) before 
analysis by fluorescence microscopy.
Confocal microscopy 
Samples were examined using a Zeiss 510 confocal 
microscope (Carl Zeiss, Jena, Germany) equipped with 
lasers giving excitation lines at 405, 488 and 543 nm. Data 
from the channels were collected separately using narrow-
band-pass filter settings. In multiple staining experiments, 
the laser intensities were adjusted to avoid bleedthrough 
between channels. Data were collected with two- to fourfold 
averaging at resolution of 1024 × 1024 pixels using pinhole 
settings between 1.05 and 1.10 airy units. Data sets were 
processed using Zeiss 510 version 2.8 software package 
and were subsequently exported for preparation for printing 
using Adobe Photoshop, version CS5.1.
Other methods for estimation of cell cycle 
parameters
In the methods described below BrdU was 
administered either as a single pulse or in association 
with a second, distinct pulse with EdU (double-pulsing). 
Asynchronous cultures of HCT-116 cells were grown on 
glass coverslips before fixation and microscopic analysis.
To estimate the absolute durations of G2 and S phases 
HCT-116 cells were briefly pulsed with BrdU (10 µM, 
15 min) and chased in BrdU-free medium for incremental 
periods of time from 3 to 11 h (1 h increments) before 
collection.  Cells were then fixed in paraformaldehyde and 
immunostained for BrdU as described herein. After staining 
of DNA with DAPI (0.5 μg/mL) cell populations were 
scored for the presence of BrdU-positive mitotic cells under 
the fluorescence microscope (Olympus BX50). G2 length 
was estimated as the shorter chasing time that resulted 
in ≈50% of BrdU-labeled mitotic cells, and the duration 
of S phase as the interval of time during which ≥ 50% 
of mitotic cells displayed staining for BrdU [13, 27].
Duration of the G1 plus G2 phases of the cell cycle 
was assessed using a cumulative (or saturation) labeling 
method [32]. Briefly, exponentially growing HCT-116 
cells were continuously pulsed with BrdU (10 µM) for 
incremental periods from 1.5 h to 9 h (1.5 h increments) 
before collection. Cells were fixed in paraformaldehyde 
and immunostained for BrdU, and the percentage of 
BrdU-positive cells was scored for each time point. The 
duration of G1 + G2 stages was estimated as the minimum 
pulsing time required for ≈100% of the cells to become 
positive for BrdU [33].
To judge the absolute length of S phase we also used 
the so-called “leaving fraction” method [28, 29]. To this 
end, HCT-116 cells were first pulsed with BrdU (10 µM, 
15 min) and chased in BrdU-free medium for 75 min before 
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exposure to a second pulse with EdU (15 µM, 15 min). 
Cells were then processed for the simultaneous detection 
of BrdU and EdU, as described here. The leaving fraction, 
corresponding to the fraction of cells that although initially 
in S phase – and thus BrdU-positive - have left S phase 
during the chasing period (thus EdU-negative) was used 
for extrapolation of the length of S phase according to the 
formula: BrdUpositive/BrdUpositive + EdUnegative X chase time 
(h) = Length of S (h). 
Cell cycle synchronization
In order to synchronize exponentially growing 
HCT116 cells at G1/S phase transition, we used the 
double-thymidine block approach. Briefly, cells were 
incubated in culture medium containing thymidine at a 
final concentration of 2 mM for 12 h (1st thymidine block), 
allowing time for cells to arrest in S phase. Thymidine 
was removed through repeated washes with fresh medium 
and cells were incubated with fresh thymidine-free 
medium for 7.5 h, to allow full exit from S phase. Cells 
were subsequently incubated with 2 mM thymidine for 
another 12 h (2nd thymidine block) to obtain a population 
precisely arrested at the G1/S phase transition that will 
progress into S phase upon release from thymidine. 
Metaphase spreads
Metaphase spreads were prepared as described 
[43]. EdU-substituted DNA was detected using the Click-
iT assay exactly as described herein for flow cytometry 
except that the 100 µL of reaction buffer were applied 
per coverslip (4 cm2). Total DNA was stained with DAPI 
(0.5 μg/mL) immediately before mounting in Vectashield 
and imaging by confocal microscopy.
Western blotting
For immunoblotting, cell lysates prepared in boiling 
1X Laemmli´s sample buffer were supplemented with 
PMSF (1 mM) and a commercially available mixture of 
protease inhibitors (Complete Mini EDTA-free; Roche 
Diagnostics, Mannheim, Germany; 1 tablet/mL). DNA 
was first fragmented mechanically by passing the sample 
into a syringe (≈10 times) through a 25-gauge needle and, 
subsequently, after supplementation with MgCl2 (5 mM), 
by digestion with benzonase (0.4 Units/ml; Sigma-
Aldrich) for 30 min at room temperature. Lysates were 
then separated on 12 or 14% SDS-PAGE under reducing 
conditions and transferred to nitrocellulose membranes 
(Schleicher & Schuel, Keene, NH). Membranes were 
blocked for 1 h with 5% nonfat dry milk powder in PBS 
and incubated for a minimum of 2 h with the specific 
primary and secondary antibodies. Antibodies used for 
immunoblotting were diluted in PBS supplemented with 
nonfat dry milk (2.5%) and Triton X-100 (0.05%) and 
used at the following dilutions: anti-phospho-RPA32/
RPA2 (Ser4/Ser8; 1/2000), anti-RPA32/RPA2 (total 
RPA32; 1/1000), anti-phospho-histone H2A.X (Ser139; 
1/1000), anti-histone H2A.X (total H2A.X; 1/1000), and 
peroxidase-conjugated affinity-purified goat anti-mouse 
and goat anti-rabbit were diluted at 1/3000. Total H2A.X 
provided loading controls. The detection reaction was 
developed by enhanced chemoluminescent (ECL) staining 
according to the specifications of the manufacturer (ECL 
Amersham, Western Blotting Detection Reagents, UK).
Alkaline comet assay 
DNA strand breaks were measured using Trevigen 
Comet Assay kit (Trevigen Inc., Gaithersburg, MD, 
USA). Cells were resuspended in ice cold PBS (Ca2+ and 
Mg2+ free) to a concentration of 1 × 105 cells/ml. A 5 μl 
aliquot of cells was added to 50 μl of molten 1% low-
melting agarose warmed to 37 °C. 50 μl were immediately 
pipetted and evenly spread onto the comet slides. Slides 
were incubated at 4°C in the dark for 10 min to accelerate 
gelling of the agarose disc and then transferred to 
prechilled lysis solution (2.5 M NaCl, 100 mM EDTA, 
10 mM Tris-base, 1% sodium lauryl sarcosinate, 1% 
Triton X-100, pH 10) for 30 min at 4°C. A denaturation 
step was performed in alkali solution (300 mM NaOH, 
1 mM EDTA, pH > 13) at room temperature for 30 min 
in the dark. Slides were then transferred to prechilled 
alkaline electrophoresis solution pH > 13 (300 mM NaOH, 
1 mM EDTA) and subjected to electrophoresis at 1 V/cm, 
300 mA for 30 min in the dark at 4°C. Subsequently, the 
slides were washed with deionized water and immersed 
in 70% ethanol at room temperature for 5 min and air 
dried. DNA was stained with 100 μl of SYBR Green I 
dye (supplied with the kit) for 10 min at 4°C in the dark 
and immediately analyzed using a CCD camera (Roper 
Scientific Coolsnap HQ CCD, Roper Technologies Inc., 
Sarasota, FA, USA) attached to a Zeiss Axiovert 200 M 
wide field fluorescence microscope. For each slide, 100 
randomly chosen comets were analyzed with an excitation 
filter of 450–490 nm and an emission filter of 515 nm. 
Images were scored for tail length and percentage of DNA 
in tail using the Tritek CometScore Freeware v1.5 image 
analysis software (TriTek Corp., Sumerduck, VA, USA). 
Statistical analysis 
Data are reported as the mean ± SD.  Results were 
compared by 2-tailed Student’s t test for two groups 
and one-way ANOVA followed by Dunnett’s multiple 
comparison test for multiple groups. GraphPad Prism 
version 5.03 for Windows (GraphPad Software, La Jolla, 
CA, USA) was used for statistical analysis. Differences 
were considered statistically significant at P < 0.05.
 When using incremental pulsing times with EdU 
in the context of EdU -Coupled-Fluorescence-Intensity 
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analysis (E-CFI), the duration of S phase was estimated 
as the first time point after which maximal EdU-coupled 
fluorescence intensities clustered within 2 SDs from each 
other. Also in the context of E-CFI, total length of cell 
cycle was estimated from the lengths of G1, G2 and S 
phases by standard error propagation.
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